pyropheophorbide a has been researched along with Ovarian Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, DQ; Chen, Q; Jiang, Y; Kong, YH; Li, KT; Pan, L; Tian, S; Yong, M; Yu, LH; Yu, TH; Zhang, L; Zhu, J | 1 |
| Chen, J; Clarke, B; Liu, TW; Macdonald, TD; Neel, BG; Shi, J; Stewart, JM; Wilson, BC; Zheng, G | 1 |
| Hoopes, PJ; Paulsen, KD; Pogue, BW; Savellano, MD; Vitetta, ES | 1 |
3 other study(ies) available for pyropheophorbide a and Ovarian Neoplasms
| Article | Year |
|---|---|
Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Chlorophyll; Down-Regulation; Female; Heme Oxygenase (Decyclizing); Humans; MAP Kinase Signaling System; Mice; Neoplasm Proteins; NF-E2-Related Factor 2; Ovarian Neoplasms; Oxidative Stress; Photochemotherapy; Reactive Oxygen Species; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
Biologically-targeted detection of primary and micro-metastatic ovarian cancer.
Topics: Animals; Cell Line, Tumor; Chlorophyll; Female; Folate Receptor 1; Folic Acid; Humans; Mice; Microscopy, Fluorescence; Molecular Diagnostic Techniques; Ovarian Neoplasms; Positron-Emission Tomography; Staining and Labeling | 2013 |
Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates.
Topics: Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Epitopes; Female; Humans; Immunotherapy; Immunotoxins; Ovarian Neoplasms; Photochemotherapy; Photosensitizing Agents; Receptor, ErbB-2 | 2005 |